Atlas Trials

AGO Research GmbH

8 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch AGO Research GmbH

RecordFirmDate
Pembrolizumab Combination With Lenvatinib in Pts With Recurrent,Persistent,Metastatic or Locally Advanced Vulvar Cancer Not Amenable to Curative Surgery or Radiotherapy (NCT05903833)AGO Research GmbH2025-06-24
Study to Estimate Efficacy of Combining Dostarlimab and Niraparib in Relapsed EOC After Treatment With PARPi (NCT05126342)AGO Research GmbH2023-11-01
WoO: Window of Opportunity Trial of Olaparib and Durvalumab in Histologically Proven EOC (NCT04644289)AGO Research GmbH2022-05-05
Mirvetuximab Soravtansine (IMGN853), in Folate Receptor Alpha (FRα) High Recurrent Ovarian Cancer (NCT04274426)AGO Research GmbH2021-10-13
Evaluation of Symptom Benefit Rate of Trabectedin/PLD in Patients With Recurrent Ovarian Cancer (NCT03690739)AGO Research GmbH2019-08-09
Atezolizumab With Bevacizumab and Chemotherapy vs Bevacizumab and Chemotherapy in Early Relapse Ovarian Cancer (NCT03353831)AGO Research GmbH2018-09-11
Prevalence of BRCA in Patients With Ovarian Cancer (NCT02222883)AGO Research GmbH2015-03-01
Evaluation of Optimal Treatment With Bevacizumab in Patients With Platinum-sensitive Recurrent Ovarian Cancer (NCT01837251)AGO Research GmbH2013-05-01

Track AGO Research GmbH automatically

Every clearance here is in the API, with alerts when new ones post.